Specific microRNAs are downregulated in human thyroid anaplastic carcinomas

被引:309
作者
Visone, R.
Pallante, P.
Vecchione, A.
Cirombella, R.
Ferracin, M.
Ferraro, A.
Volinia, S.
Coluzzi, S.
Leone, V.
Borbone, E.
Liu, C-G
Petrocca, F.
Troncone, G.
Calin, G. A.
Scarpa, A.
Colato, C.
Tallini, G.
Santoro, M.
Croce, C. M.
Fusco, A.
机构
[1] Univ Naples Federico II, Fac Med & Chirurg, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Pathol, I-80131 Naples, Italy
[2] European Sch Mol Med, Biotechnol Avanzate Napoli & SEMM, NOGEC, CEINGE, Naples, Italy
[3] Ohio State Univ, Columbus, OH 43210 USA
[4] Univ Roma La Sapienza, Dip Istopathol, Osped St Andrea, Dipartimento Anat Umana & Istol, Rome, Italy
[5] Univ Ferrara, Ctr Interdipartipartmental Ricerca Cancro, Dipartimento Med Sperimentale & Diagnost, Ferrara, Italy
[6] Univ Naples 2, Fac Med & Chirurg, Dipartimoento Anat Patol & Citopatol, Naples, Italy
[7] Univ Verona, Dipartimento Patol, Verona, Italy
[8] Univ Bologna, Osped Bellaria, Dipartimento Patol Sperimentale, Bologna, Italy
关键词
microRNA; miR-30d; miR-125b; miR-26a; miR-30a-5p; thyroid anaplastic carcinoma;
D O I
10.1038/sj.onc.1210564
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thyroid carcinomas comprise a broad spectrum of tumors with different clinical behaviors. On the one side, there are occult papillary carcinomas (PTC), slow growing and clinically silent, and on the other side, rapidly growing anaplastic carcinomas (ATC), which are among the most lethal human neoplasms. We have analysed the microRNA (miR) pro. le of ATC in comparison to the normal thyroid using a microarray (miRNACHIP microarray). By this approach, we found an aberrant miR expression pro. le that clearly differentiates ATC from normal thyroid tissues and from PTC analysed in previous studies. In particular, a significant decrease in miR-30d, miR-125b, miR-26a and miR-30a-5p was detected in ATC in comparison to normal thyroid tissue. These results were further confirmed by northern blots, quantitative reverse transcription-PCR analyses and in situ hybridization. The overexpression of these four miRs in two human ATC-derived cell lines suggests a critical role of miR-125b and miR-26a downregulation in thyroid carcinogenesis, since a cell growth inhibition was achieved. Conversely, no effect on cell growth was observed after the overexpression of miR-30d and miR-30a-5p in the same cells. In conclusion, these data indicate a miR signature associated with ATC and suggest the miR deregulation as an important event in thyroid cell transformation.
引用
收藏
页码:7590 / 7595
页数:6
相关论文
共 31 条
[1]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[2]   Thyroid cell transformation requires the expression of the HMGA1 proteins [J].
Berlingieri, MT ;
Pierantoni, GM ;
Giancotti, V ;
Santoro, M ;
Fusco, A .
ONCOGENE, 2002, 21 (19) :2971-2980
[3]  
Califano D, 1998, CANCER RES, V58, P823
[4]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[5]   A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia [J].
Calin, GA ;
Ferracin, M ;
Cimmino, A ;
Di Leva, G ;
Shimizu, M ;
Wojcik, SE ;
Iorio, MV ;
Visone, R ;
Sever, NI ;
Fabbri, M ;
Iuliano, R ;
Palumbo, T ;
Pichiorri, F ;
Roldo, C ;
Garzon, R ;
Sevignani, C ;
Rassenti, L ;
Alder, H ;
Volinia, S ;
Liu, CG ;
Kipps, TJ ;
Negrini, M ;
Croce, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1793-1801
[6]  
Cerutti J, 1996, CLIN CANCER RES, V2, P119
[7]   MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells [J].
Chan, JA ;
Krichevsky, AM ;
Kosik, KS .
CANCER RESEARCH, 2005, 65 (14) :6029-6033
[8]  
CHIAPPETTA G, 1995, ONCOGENE, V10, P1307
[9]  
de Nigris F, 1998, CANCER RES, V58, P4745
[10]   GENE P53 MUTATIONS ARE RESTRICTED TO POORLY DIFFERENTIATED AND UNDIFFERENTIATED CARCINOMAS OF THE THYROID-GLAND [J].
DONGHI, R ;
LONGONI, A ;
PILOTTI, S ;
MICHIELI, P ;
DELLAPORTA, G ;
PIEROTTI, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) :1753-1760